As of Jun 06
| +0.0019 / +6.76%|
The 1 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +6,566.67% increase from the last price of 0.03.
The current consensus among 1 polled investment analysts is to Sell stock in Clovis Oncology Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.